Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Ujvera 100 trastumab emtansine

₹ 18,500/Piece

Dosage FormInjection
TreatmentBreast Cancer
Packaging TypeVial
BrandVivitra
ManufacturerRoche
Strength440 mg
Brand NameUjvera 100 mg
Manufactured ByZydilus
UsageHospital
Shelf Life36 months
Country of OriginMade in India
AvailabilityIn Stock
View in Hindi उजवेरा ट्रैस्टुज़ुमैब एमटैन्सिन वायल

Ujvira 100 mg Injection is used to treat Breast Cancer and Stomach Cancer. How does Ujvira 100 mg Injection work? Ujvira 100 mg Injection contains Trastuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells.

Exports To: Sri Lanka | Saudi Arabia | United Arab Emirates | Oman | Qatar

Find products similar to Ujvera 100 Trastumab Emtansine

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromChennai
ShippingAs per delivery location

Product Image

Ujvera 100 trastumab emtansine-1Ujvera 100 trastumab emtansine-2

About the Company

GST Registration Date
Mar 2023
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Mar 2023
GST
33**********1Z1
Import Export Code (IEC)
*******03K
Exports to
Sri Lanka | Saudi Arabia | United Arab Emirates | Oman | Qatar

Established in the year of 2021, We “BSM Health CareWholesaler of Pharmaceutical Tablets, Pharmaceutical Injection, Pharmaceutical Capsules, Anti Cancer Injections and many more. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to Mr. Magesh Babu, whose continual backing and direction have been useful to us for attaining exponential development in the current market.